| ADR Ontology |
| ADR Term |
Haemangioblastoma |
| ADR ID |
BADD_A09995 |
| ADR Hierarchy |
|
| Description |
A benign tumor of the nervous system that may occur sporadically or in association with VON HIPPEL-LINDAU DISEASE. It accounts for approximately 2% of intracranial tumors, arising most frequently in the cerebellar hemispheres and vermis. Histologically, the tumors are composed of multiple capillary and sinusoidal channels lined with endothelial cells and clusters of lipid-laden pseudoxanthoma cells. Usually solitary, these tumors can be multiple and may also occur in the brain stem, spinal cord, retina, and supratentorial compartment. Cerebellar hemangioblastomas usually present in the third decade with INTRACRANIAL HYPERTENSION, and ataxia. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2071-2) [MeSH] |
| MedDRA Code |
10018813 |
| MeSH ID |
D018325
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Haemangioblastoma | Hemangioblastoma | Hemangioblastomas | Multiple Hemangioblastomas | Hemangioblastoma, Multiple | Hemangioblastomas, Multiple | Multiple Hemangioblastoma |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00858 | Everolimus | 0.000153% | |
| The 1th Page 1
Total 1 Pages
|
|
